chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Blood sodium decreased, COVID-19, COVID-19 pneumonia, Cardiac failure acute, Chronic obstructive pulmonary disease
Clinical narrative: COVID Breakthrough Case  Pfizer Dose 1 1/18/21 (lot not listed in database) Pfizer Dose 2 2/8/21 (lot not listed in database) COVID Positive 9/12/21 (approximately)  9/19/21: Patient is a 83 year old elderly female from a facility who was brought to ED via EMS for a progressively worsening cough. She has a past medical history of asthma, atrial fibrillation not on anticoagulation, CKD stage 3, diastolic heart failure LVEF 67%, COPD, hypertension, hyperlipidemia, mitral regurgitation, pulmonary hypertension and dementia. Patient is a poor historian and history was obtained per chart review and from ER staff. Per chart review patient was diagnosed with Covid-19 approximately a week ago. She has had increased shortness of breath, cough, vomiting and diarrhea.  On arrival to ED patient was febrile 99.2, hypertensive 179/79 and saturating at 89% on room air. Supplemental oxygen was applied 2L NC with improvement in oxygen saturation to 94%.  Laboratory findings were significant for hyponatremia 126. CKD stage G3b.  Transaminitis ALT 189 and AST 218. ProBNP 4058. Troponin 0.06.  Anemia HGB 11.5. D-dimer 1.01.  CT chest negative for PE.  Ground-glass airspace disease in all 5 lobes likely representing multifocal pneumonia versus viral pneumonitis.  Rocephin and Zithromax initiated in ED.  DuoNeb treatment and Decadron given in ED.  Ativan given for agitation.  9/27/21: 83-year-old female was brought in due to persistent cough and shortness of breath, admitted for acute hypoxic respiratory failure secondary to bilateral community-acquired pneumonia secondary to COVID-19 pneumonia so she with COPD exacerbation, also had component of acute on chronic diastolic heart failure.  Pt received Actemra, completed remdesivir, finished IV antibiotics, started on some steroids, respiratory status significantly improved however remained on low-dose oxygen. Remained stable throughout hospitalization and was stable for discharge.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram thorax abnormal, Condition aggravated, Cough, Diarrhoea, Dyspnoea
Clinical narrative: COVID Breakthrough Case  Pfizer Dose 1 1/18/21 (lot not listed in database) Pfizer Dose 2 2/8/21 (lot not listed in database) COVID Positive 9/12/21 (approximately)  9/19/21: Patient is a 83 year old elderly female from a facility who was brought to ED via EMS for a progressively worsening cough. She has a past medical history of asthma, atrial fibrillation not on anticoagulation, CKD stage 3, diastolic heart failure LVEF 67%, COPD, hypertension, hyperlipidemia, mitral regurgitation, pulmonary hypertension and dementia. Patient is a poor historian and history was obtained per chart review and from ER staff. Per chart review patient was diagnosed with Covid-19 approximately a week ago. She has had increased shortness of breath, cough, vomiting and diarrhea.  On arrival to ED patient was febrile 99.2, hypertensive 179/79 and saturating at 89% on room air. Supplemental oxygen was applied 2L NC with improvement in oxygen saturation to 94%.  Laboratory findings were significant for hyponatremia 126. CKD stage G3b.  Transaminitis ALT 189 and AST 218. ProBNP 4058. Troponin 0.06.  Anemia HGB 11.5. D-dimer 1.01.  CT chest negative for PE.  Ground-glass airspace disease in all 5 lobes likely representing multifocal pneumonia versus viral pneumonitis.  Rocephin and Zithromax initiated in ED.  DuoNeb treatment and Decadron given in ED.  Ativan given for agitation.  9/27/21: 83-year-old female was brought in due to persistent cough and shortness of breath, admitted for acute hypoxic respiratory failure secondary to bilateral community-acquired pneumonia secondary to COVID-19 pneumonia so she with COPD exacerbation, also had component of acute on chronic diastolic heart failure.  Pt received Actemra, completed remdesivir, finished IV antibiotics, started on some steroids, respiratory status significantly improved however remained on low-dose oxygen. Remained stable throughout hospitalization and was stable for discharge.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Fibrin D dimer, Haemoglobin decreased, Hypertension, Hyponatraemia, Laboratory test
Clinical narrative: COVID Breakthrough Case  Pfizer Dose 1 1/18/21 (lot not listed in database) Pfizer Dose 2 2/8/21 (lot not listed in database) COVID Positive 9/12/21 (approximately)  9/19/21: Patient is a 83 year old elderly female from a facility who was brought to ED via EMS for a progressively worsening cough. She has a past medical history of asthma, atrial fibrillation not on anticoagulation, CKD stage 3, diastolic heart failure LVEF 67%, COPD, hypertension, hyperlipidemia, mitral regurgitation, pulmonary hypertension and dementia. Patient is a poor historian and history was obtained per chart review and from ER staff. Per chart review patient was diagnosed with Covid-19 approximately a week ago. She has had increased shortness of breath, cough, vomiting and diarrhea.  On arrival to ED patient was febrile 99.2, hypertensive 179/79 and saturating at 89% on room air. Supplemental oxygen was applied 2L NC with improvement in oxygen saturation to 94%.  Laboratory findings were significant for hyponatremia 126. CKD stage G3b.  Transaminitis ALT 189 and AST 218. ProBNP 4058. Troponin 0.06.  Anemia HGB 11.5. D-dimer 1.01.  CT chest negative for PE.  Ground-glass airspace disease in all 5 lobes likely representing multifocal pneumonia versus viral pneumonitis.  Rocephin and Zithromax initiated in ED.  DuoNeb treatment and Decadron given in ED.  Ativan given for agitation.  9/27/21: 83-year-old female was brought in due to persistent cough and shortness of breath, admitted for acute hypoxic respiratory failure secondary to bilateral community-acquired pneumonia secondary to COVID-19 pneumonia so she with COPD exacerbation, also had component of acute on chronic diastolic heart failure.  Pt received Actemra, completed remdesivir, finished IV antibiotics, started on some steroids, respiratory status significantly improved however remained on low-dose oxygen. Remained stable throughout hospitalization and was stable for discharge.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Left ventricular failure, Lung opacity, Pneumonia, Pneumonia viral, Prohormone brain natriuretic peptide increased
Clinical narrative: COVID Breakthrough Case  Pfizer Dose 1 1/18/21 (lot not listed in database) Pfizer Dose 2 2/8/21 (lot not listed in database) COVID Positive 9/12/21 (approximately)  9/19/21: Patient is a 83 year old elderly female from a facility who was brought to ED via EMS for a progressively worsening cough. She has a past medical history of asthma, atrial fibrillation not on anticoagulation, CKD stage 3, diastolic heart failure LVEF 67%, COPD, hypertension, hyperlipidemia, mitral regurgitation, pulmonary hypertension and dementia. Patient is a poor historian and history was obtained per chart review and from ER staff. Per chart review patient was diagnosed with Covid-19 approximately a week ago. She has had increased shortness of breath, cough, vomiting and diarrhea.  On arrival to ED patient was febrile 99.2, hypertensive 179/79 and saturating at 89% on room air. Supplemental oxygen was applied 2L NC with improvement in oxygen saturation to 94%.  Laboratory findings were significant for hyponatremia 126. CKD stage G3b.  Transaminitis ALT 189 and AST 218. ProBNP 4058. Troponin 0.06.  Anemia HGB 11.5. D-dimer 1.01.  CT chest negative for PE.  Ground-glass airspace disease in all 5 lobes likely representing multifocal pneumonia versus viral pneumonitis.  Rocephin and Zithromax initiated in ED.  DuoNeb treatment and Decadron given in ED.  Ativan given for agitation.  9/27/21: 83-year-old female was brought in due to persistent cough and shortness of breath, admitted for acute hypoxic respiratory failure secondary to bilateral community-acquired pneumonia secondary to COVID-19 pneumonia so she with COPD exacerbation, also had component of acute on chronic diastolic heart failure.  Pt received Actemra, completed remdesivir, finished IV antibiotics, started on some steroids, respiratory status significantly improved however remained on low-dose oxygen. Remained stable throughout hospitalization and was stable for discharge.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Transaminases increased, Troponin increased, Vaccine breakthrough infection, Vomiting
Clinical narrative: COVID Breakthrough Case  Pfizer Dose 1 1/18/21 (lot not listed in database) Pfizer Dose 2 2/8/21 (lot not listed in database) COVID Positive 9/12/21 (approximately)  9/19/21: Patient is a 83 year old elderly female from a facility who was brought to ED via EMS for a progressively worsening cough. She has a past medical history of asthma, atrial fibrillation not on anticoagulation, CKD stage 3, diastolic heart failure LVEF 67%, COPD, hypertension, hyperlipidemia, mitral regurgitation, pulmonary hypertension and dementia. Patient is a poor historian and history was obtained per chart review and from ER staff. Per chart review patient was diagnosed with Covid-19 approximately a week ago. She has had increased shortness of breath, cough, vomiting and diarrhea.  On arrival to ED patient was febrile 99.2, hypertensive 179/79 and saturating at 89% on room air. Supplemental oxygen was applied 2L NC with improvement in oxygen saturation to 94%.  Laboratory findings were significant for hyponatremia 126. CKD stage G3b.  Transaminitis ALT 189 and AST 218. ProBNP 4058. Troponin 0.06.  Anemia HGB 11.5. D-dimer 1.01.  CT chest negative for PE.  Ground-glass airspace disease in all 5 lobes likely representing multifocal pneumonia versus viral pneumonitis.  Rocephin and Zithromax initiated in ED.  DuoNeb treatment and Decadron given in ED.  Ativan given for agitation.  9/27/21: 83-year-old female was brought in due to persistent cough and shortness of breath, admitted for acute hypoxic respiratory failure secondary to bilateral community-acquired pneumonia secondary to COVID-19 pneumonia so she with COPD exacerbation, also had component of acute on chronic diastolic heart failure.  Pt received Actemra, completed remdesivir, finished IV antibiotics, started on some steroids, respiratory status significantly improved however remained on low-dose oxygen. Remained stable throughout hospitalization and was stable for discharge.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: no adverse side effects known given expired dose
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chest discomfort, Dizziness, Hypoaesthesia oral, Panic attack
Clinical narrative: Weak feeling, dizziness, tightness in chest, unable to talk, numbness in mouth and throat. Suffering panic attacks.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Pharyngeal hypoaesthesia, Speech disorder
Clinical narrative: Weak feeling, dizziness, tightness in chest, unable to talk, numbness in mouth and throat. Suffering panic attacks.
Age: 54.0
Sex: M
Vaccine: UNK
Symptoms: Arthralgia, Headache, Hypoaesthesia, Pain, Pain in extremity
Clinical narrative: sore jaw temples and numbness and pain throughout body worse in hands and feet.  Achy joints  symptoms have worsened and remain to date .  Diagnosed as small fiber neuropathy
Age: 54.0
Sex: M
Vaccine: UNK
Symptoms: Pain in jaw, Small fibre neuropathy
Clinical narrative: sore jaw temples and numbness and pain throughout body worse in hands and feet.  Achy joints  symptoms have worsened and remain to date .  Diagnosed as small fiber neuropathy
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Inflammation, Pain in extremity, Peripheral swelling, Swelling face
Clinical narrative: Swelling in right leg 2 weeks later. 4 weeks later extreme swelling in both legs. Pain and extreme inflammation in knees and legs. 6 weeks later extreme swelling in hands, face, and legs.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: X-ray
Clinical narrative: Swelling in right leg 2 weeks later. 4 weeks later extreme swelling in both legs. Pain and extreme inflammation in knees and legs. 6 weeks later extreme swelling in hands, face, and legs.
Age: 96.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, Acute respiratory failure, Atrial flutter, COVID-19, Cardiac failure congestive
Clinical narrative: COVID Breakthrough Case  Pfizer Dose 1 2/20/21 (el3302) Pfizer Dose 2 3/5/21 (EN6199) COVID Positive 9/20/21  9/21/21: 97-year-old lady presented to the emergency room with complaint of shortness of breath.  The patient reports shortness of breath with activity.  She reports fever.  She was tested positive for COVID- 19 infection and received an antibody infusion today.  She denied nausea, vomiting, diarrhea.  She was discharged from the hospital about 3 weeks ago for the management of CHF and atrial flutter.  9/27/21: 97-year-old female with heart failure with preserved ejection fraction presented with worsening shortness of breath, received outpatient antibody infusion for recent COVID-19 diagnosis.  No pulmonary embolism on chest CT.  Patient admitted for acute hypoxic respiratory failure secondary to COVID-19, sepsis and diastolic heart failure exacerbation.  She was initially on BiPAP subsequently weaned off to room air.  Treated with IV diuretics, worsening acute kidney injury. diuretics discontinued renal function subsequently improved.  PTOT evaluated patient and recommended in-home therapies and patient will be discharged with VNA.  Patient lives alone, daughters are planning to stay with the patient  for the next several days with the patient . On discharge patient was afebrile and hemodynamically stable.  She was discharged home.
Age: 96.0
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram thorax normal, Condition aggravated, Dyspnoea, Dyspnoea exertional, Left ventricular failure
Clinical narrative: COVID Breakthrough Case  Pfizer Dose 1 2/20/21 (el3302) Pfizer Dose 2 3/5/21 (EN6199) COVID Positive 9/20/21  9/21/21: 97-year-old lady presented to the emergency room with complaint of shortness of breath.  The patient reports shortness of breath with activity.  She reports fever.  She was tested positive for COVID- 19 infection and received an antibody infusion today.  She denied nausea, vomiting, diarrhea.  She was discharged from the hospital about 3 weeks ago for the management of CHF and atrial flutter.  9/27/21: 97-year-old female with heart failure with preserved ejection fraction presented with worsening shortness of breath, received outpatient antibody infusion for recent COVID-19 diagnosis.  No pulmonary embolism on chest CT.  Patient admitted for acute hypoxic respiratory failure secondary to COVID-19, sepsis and diastolic heart failure exacerbation.  She was initially on BiPAP subsequently weaned off to room air.  Treated with IV diuretics, worsening acute kidney injury. diuretics discontinued renal function subsequently improved.  PTOT evaluated patient and recommended in-home therapies and patient will be discharged with VNA.  Patient lives alone, daughters are planning to stay with the patient  for the next several days with the patient . On discharge patient was afebrile and hemodynamically stable.  She was discharged home.
Age: 96.0
Sex: F
Vaccine: COVID19
Symptoms: Positive airway pressure therapy, Pyrexia, SARS-CoV-2 test positive, Sepsis, Vaccine breakthrough infection
Clinical narrative: COVID Breakthrough Case  Pfizer Dose 1 2/20/21 (el3302) Pfizer Dose 2 3/5/21 (EN6199) COVID Positive 9/20/21  9/21/21: 97-year-old lady presented to the emergency room with complaint of shortness of breath.  The patient reports shortness of breath with activity.  She reports fever.  She was tested positive for COVID- 19 infection and received an antibody infusion today.  She denied nausea, vomiting, diarrhea.  She was discharged from the hospital about 3 weeks ago for the management of CHF and atrial flutter.  9/27/21: 97-year-old female with heart failure with preserved ejection fraction presented with worsening shortness of breath, received outpatient antibody infusion for recent COVID-19 diagnosis.  No pulmonary embolism on chest CT.  Patient admitted for acute hypoxic respiratory failure secondary to COVID-19, sepsis and diastolic heart failure exacerbation.  She was initially on BiPAP subsequently weaned off to room air.  Treated with IV diuretics, worsening acute kidney injury. diuretics discontinued renal function subsequently improved.  PTOT evaluated patient and recommended in-home therapies and patient will be discharged with VNA.  Patient lives alone, daughters are planning to stay with the patient  for the next several days with the patient . On discharge patient was afebrile and hemodynamically stable.  She was discharged home.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Interchange of vaccine products, No adverse event
Clinical narrative: MA was giving a COVID injection to Pt at noon time for Dr. MA brought it to Dr.'s attention that the pt had the 1st Covid Moderna injections but did not get the second. Dr. stated when she was approached about the pt getting the Pfizer vaccine she misunderstood MA and though it was a booster shot even though MA stated to her she only got the first Moderna. Dr. then stated she though the first injection was back in July not November. Dr. MA though she would have to start the series over again anyway so she gave the OK to MA to give it to her.       After injection was given we tried to enter it into the pt chart and it would not let us because it stated that the pt should not be receiving the Pfizer because she needed to finish the Moderna series. I though this was a red flag so I contacted staff from our quality department and she stated we have to call Pfizer and report the error. I called Pfizer and they stated they can send us information about the two injections but they were not allowed to advise on if what happened was ok or not. They stated if we needed more information that we would have to call the CDC.          I then proceeded to call the CDC to report the error and to get clinical advise from someone to relay information back to the quality department as well as the patient. They sent an email advising on the process and effects of mixing the Moderna and the Pfizer. They stated the only difference is that she would have to get the Pfizer shot only when it is time for her Booster. Other than that they said there was no need for any concerns. After pt got the vaccine she waiting the standard 20 mins for observation and had no issues at all. Pt was called after the call with the CDC and was made a wear of what the concerns were on our end and was told she could only have the Pfizer Vaccine as a Booster.  * I just want to state again that pt did NOT have any reaction to the injection and she did wait 20 mins after we injected her to see if she would.
Age: 35.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Tinnitus
Clinical narrative: Experienced significant tinnitus, often during afternoon hours, for several months after receiving my two pfizer covid vaccine doses.  Seems to have subsided after several months of symptoms.  No changes in exposure to loud noise levels during this period.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Antibody test, Full blood count, Laboratory test, Muscle enzyme, Pain in extremity
Clinical narrative: Insidious onset of debilitating lower extremity pain.  It has worsened over months to the point that medical assessments have been made without a definitive diagnosis found
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Spinal X-ray
Clinical narrative: Insidious onset of debilitating lower extremity pain.  It has worsened over months to the point that medical assessments have been made without a definitive diagnosis found
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Autoimmune disorder, Eye disorder, Pain in extremity, Polymyalgia rheumatica
Clinical narrative: Starting in May I began to take a low dose of Lamictal, I had chapped lips that would crack for about 2 months steadily getting worse. In July over the period of 48 hours of being told to double the Lamictal, I got a chemical burn across my tongue, throat and urinary tract, I was then diagnosed to have SJS, Steven Johnson Syndrome by the hospital that I visited where they said that this is usually resulting in fatality. Taken off of Lamictal and became non critical and was discharged. I still have burning in my lips and urinary tract, however it is not incapacitating and my lips have returned to normal color. I have some eye problems that have developed that may or may not be associated. I began to develop a second autoimmune disease in October, it started out as pain in my legs and hard to move my leg, which then progressed across all of my joints and became extremely painful. I was given the diagnosis of polymyalgia rheumatica and was given prednisone for treatment option. and is pending full diagnosis. Prednisone has seems to help with about 75%. I am scheduled to see a rheumatologist in a week for check-up.
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Pedi Pfizer administered to 12 year old.
Age: 89.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Aortic disorder, Asthenia, Asymptomatic COVID-19, Atelectasis, Cardiomegaly
Clinical narrative: Pt presented to the ED on 1/14/22 for weakness, dark tarry stools and vomiting x2 days.  Denied chest pain, chills, headache, SOB.  XR Chest 1V [Auth (Verified)] (01/14 2018): FINAL IMPRESSION: Cardiomegaly with an atherosclerotic tortuous aorta.Right perihilar atelectasis versus fibrotic change.  Pt admitted for GI bleed.  Remained asymptotic for COVID through hospitalization.  Was discharged 1/27/2022.  Previously vaccinated Pfizer 2/1/21 & 2/23/21.
Age: 89.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest X-ray abnormal, Gastrointestinal haemorrhage, Melaena, Pulmonary fibrosis, SARS-CoV-2 test positive
Clinical narrative: Pt presented to the ED on 1/14/22 for weakness, dark tarry stools and vomiting x2 days.  Denied chest pain, chills, headache, SOB.  XR Chest 1V [Auth (Verified)] (01/14 2018): FINAL IMPRESSION: Cardiomegaly with an atherosclerotic tortuous aorta.Right perihilar atelectasis versus fibrotic change.  Pt admitted for GI bleed.  Remained asymptotic for COVID through hospitalization.  Was discharged 1/27/2022.  Previously vaccinated Pfizer 2/1/21 & 2/23/21.
Age: 89.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vomiting
Clinical narrative: Pt presented to the ED on 1/14/22 for weakness, dark tarry stools and vomiting x2 days.  Denied chest pain, chills, headache, SOB.  XR Chest 1V [Auth (Verified)] (01/14 2018): FINAL IMPRESSION: Cardiomegaly with an atherosclerotic tortuous aorta.Right perihilar atelectasis versus fibrotic change.  Pt admitted for GI bleed.  Remained asymptotic for COVID through hospitalization.  Was discharged 1/27/2022.  Previously vaccinated Pfizer 2/1/21 & 2/23/21.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Epistaxis
Clinical narrative: Nose bleeding, that continues for 10 min several times a day.  it started 4 days ago and still continues. She never had a nose bleed before.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Device malfunction, Myalgia, Respiratory tract congestion
Clinical narrative: Patient states they received the Pfizer two dose series, first in July, second in August 2021.  Unable to provide exact dates nor the facility where she received the vaccines.   Patient presented to ED after having her AICD misfire X 5.  Did report mild congestion, cough and myalgias that began two days prior to presentation to ED.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Patient states they received the Pfizer two dose series, first in July, second in August 2021.  Unable to provide exact dates nor the facility where she received the vaccines.   Patient presented to ED after having her AICD misfire X 5.  Did report mild congestion, cough and myalgias that began two days prior to presentation to ED.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Exposure to SARS-CoV-2, Fatigue, Rhinorrhoea
Clinical narrative: Exposure to COVID by family member prompted testing of family. Tested for COVID 19: 01/03/2022, sneezing running noise cough and fatigue but no fevers. Positive for COVID 19: 01/07/2022 Re-tested.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Sneezing
Clinical narrative: Exposure to COVID by family member prompted testing of family. Tested for COVID 19: 01/03/2022, sneezing running noise cough and fatigue but no fevers. Positive for COVID 19: 01/07/2022 Re-tested.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Injection site pain, Pain, Pyrexia, Tinnitus
Clinical narrative: Fever, vomiting, aches, tinnitus, headache, injection site pain
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Fever, vomiting, aches, tinnitus, headache, injection site pain
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Mobility decreased
Clinical narrative: At 5:15 on 4/11/21, patient had a slight headache and laid down  At 6:30, patient's wife woke him. Patient then noticed that he could not move his legs or toes, it was as if his toes were frozen.  Patient's wife and niece began messaging his legs for about 30 minutes. They were able to slide his legs over the side of the bed and helped him stand. After that he was able to walk without assistance. Patient has been advised to NOT receive the booster per his PCP. Patient presented this report to the pharmacy on 1/27/22.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: given expired vaccine Pt. contacted no adverse effects
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Nausea
Clinical narrative: Pt vaccinated in the supine position.  Pt reported dizziness and nausea Vitals: 16: 15 122/92, 64, 18 -- > 16:20 HR 78, 16:30 120/80, 72 Pt stable and released from the vaccination site @16:30
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Condition aggravated, Diarrhoea, Dizziness, Feeling abnormal, Joint swelling
Clinical narrative: First shot 11/6/21 Sat; on Tues 11/9/21 started diarrhea and overall icky feeling. Wed 11/10/21 start experiencing dizziness and tinnitus (never had tinnitus before).  All symptoms except tinnitus left on Friday, 11/12/21. Second shot 11/27/21 Sat around 12 noon (time not noted on my card).  At 8pm the same day, my left foot and joints in both hands swelled and the tinnitus got far worse. The tinnitus has remained ever since and it has stunted the progress I was making with my RA.  To this day it has remained. I may have to start taking injections for my RA that I cannot afford.  Silence is deafening to me now and I cannot wait until this vile "vaccine" leaves my body.  I will never take any boosters due to these medical issues.
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Peripheral swelling, Rheumatoid arthritis, Tinnitus
Clinical narrative: First shot 11/6/21 Sat; on Tues 11/9/21 started diarrhea and overall icky feeling. Wed 11/10/21 start experiencing dizziness and tinnitus (never had tinnitus before).  All symptoms except tinnitus left on Friday, 11/12/21. Second shot 11/27/21 Sat around 12 noon (time not noted on my card).  At 8pm the same day, my left foot and joints in both hands swelled and the tinnitus got far worse. The tinnitus has remained ever since and it has stunted the progress I was making with my RA.  To this day it has remained. I may have to start taking injections for my RA that I cannot afford.  Silence is deafening to me now and I cannot wait until this vile "vaccine" leaves my body.  I will never take any boosters due to these medical issues.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia
Clinical narrative: 24 hours of muscle soreness all over patient's body; chillsb and headaches.
Age: 68.0
Sex: M
Vaccine: COVID19, UNK
Symptoms: Anion gap, Blood creatinine increased, Blood gases, Blood glucose increased, Blood sodium decreased
Clinical narrative: Presented to the ED due to shortness of breath that is worse on exertion and lying flat.  Per EMS patient had oxygen saturation 70 % on room air on their arrival.  Blood sugar elevated as well.  Patient reports testing positive for COVID.  States that his sister-in-law just recently died from COVID-19.  He is vaccinated against COVID x3 doses.  Reports getting outpatient COVID treatment including steroids however symptoms continue to worsen despite this.  Patient denies lower extremity edema, palpitations, chest pain, lightheadedness, dizziness, fever or chills.   - ED workup significant for HR 91, RR 22, increased anion gap 18.  ABG reveals 7.27/32.2/57.7/14.8.  Hyperglycemia present 643, with hyponatremia 125 BUN elevated 46 and serum creatinine elevated 2.53 (baseline 1.2-1.5) - COVID-19 positive - BNP elevated 4267.  Troponin not obtained in ED.  EKG reveals normal sinus rhythm without acute ST changes.  Chest x-ray reveals bilateral pneumonia and pulmonary edema however final radiology read pending at the time of admission.  Chest x-ray worse compared to 2 days prior. Hospitalized 1/15/22.  Discharged from hospital 1/27/2022.  Previously vaccinated Moderna 4/2/21 & 4/30/21.
Age: 68.0
Sex: M
Vaccine: COVID19, UNK
Symptoms: Blood urea increased, Brain natriuretic peptide increased, COVID-19, Chest X-ray abnormal, Dyspnoea
Clinical narrative: Presented to the ED due to shortness of breath that is worse on exertion and lying flat.  Per EMS patient had oxygen saturation 70 % on room air on their arrival.  Blood sugar elevated as well.  Patient reports testing positive for COVID.  States that his sister-in-law just recently died from COVID-19.  He is vaccinated against COVID x3 doses.  Reports getting outpatient COVID treatment including steroids however symptoms continue to worsen despite this.  Patient denies lower extremity edema, palpitations, chest pain, lightheadedness, dizziness, fever or chills.   - ED workup significant for HR 91, RR 22, increased anion gap 18.  ABG reveals 7.27/32.2/57.7/14.8.  Hyperglycemia present 643, with hyponatremia 125 BUN elevated 46 and serum creatinine elevated 2.53 (baseline 1.2-1.5) - COVID-19 positive - BNP elevated 4267.  Troponin not obtained in ED.  EKG reveals normal sinus rhythm without acute ST changes.  Chest x-ray reveals bilateral pneumonia and pulmonary edema however final radiology read pending at the time of admission.  Chest x-ray worse compared to 2 days prior. Hospitalized 1/15/22.  Discharged from hospital 1/27/2022.  Previously vaccinated Moderna 4/2/21 & 4/30/21.
Age: 68.0
Sex: M
Vaccine: COVID19, UNK
Symptoms: Dyspnoea exertional, Electrocardiogram normal, Hyperglycaemia, Hyponatraemia, Pneumonia
Clinical narrative: Presented to the ED due to shortness of breath that is worse on exertion and lying flat.  Per EMS patient had oxygen saturation 70 % on room air on their arrival.  Blood sugar elevated as well.  Patient reports testing positive for COVID.  States that his sister-in-law just recently died from COVID-19.  He is vaccinated against COVID x3 doses.  Reports getting outpatient COVID treatment including steroids however symptoms continue to worsen despite this.  Patient denies lower extremity edema, palpitations, chest pain, lightheadedness, dizziness, fever or chills.   - ED workup significant for HR 91, RR 22, increased anion gap 18.  ABG reveals 7.27/32.2/57.7/14.8.  Hyperglycemia present 643, with hyponatremia 125 BUN elevated 46 and serum creatinine elevated 2.53 (baseline 1.2-1.5) - COVID-19 positive - BNP elevated 4267.  Troponin not obtained in ED.  EKG reveals normal sinus rhythm without acute ST changes.  Chest x-ray reveals bilateral pneumonia and pulmonary edema however final radiology read pending at the time of admission.  Chest x-ray worse compared to 2 days prior. Hospitalized 1/15/22.  Discharged from hospital 1/27/2022.  Previously vaccinated Moderna 4/2/21 & 4/30/21.
Age: 68.0
Sex: M
Vaccine: COVID19, UNK
Symptoms: Pulmonary oedema, SARS-CoV-2 test positive
Clinical narrative: Presented to the ED due to shortness of breath that is worse on exertion and lying flat.  Per EMS patient had oxygen saturation 70 % on room air on their arrival.  Blood sugar elevated as well.  Patient reports testing positive for COVID.  States that his sister-in-law just recently died from COVID-19.  He is vaccinated against COVID x3 doses.  Reports getting outpatient COVID treatment including steroids however symptoms continue to worsen despite this.  Patient denies lower extremity edema, palpitations, chest pain, lightheadedness, dizziness, fever or chills.   - ED workup significant for HR 91, RR 22, increased anion gap 18.  ABG reveals 7.27/32.2/57.7/14.8.  Hyperglycemia present 643, with hyponatremia 125 BUN elevated 46 and serum creatinine elevated 2.53 (baseline 1.2-1.5) - COVID-19 positive - BNP elevated 4267.  Troponin not obtained in ED.  EKG reveals normal sinus rhythm without acute ST changes.  Chest x-ray reveals bilateral pneumonia and pulmonary edema however final radiology read pending at the time of admission.  Chest x-ray worse compared to 2 days prior. Hospitalized 1/15/22.  Discharged from hospital 1/27/2022.  Previously vaccinated Moderna 4/2/21 & 4/30/21.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Angiogram pulmonary abnormal, Atelectasis, Chest pain, Computerised tomogram thorax abnormal, Lung consolidation
Clinical narrative: Patient presented with chest pain and was ruled out for COVID. had CT  chest: IMPRESSION:  1. Bilateral pulmonary emboli.  2. Normal heart ratio.  3. Bilateral lower lobe atelectasis and possible developing  pulmonary infarcts.  4. Bilateral calcified axillary lymph nodes.    PROCEDURE INFORMATION:  Exam: CTA Chest With Contrast  Exam date and time: 1/27/2022 3:06 PM  Age: 39 years old     TECHNIQUE:  Imaging protocol: Computed tomographic angiography of the  chest with contrast.  3D rendering (Not supervised by radiologist): MIP and/or 3D  reconstructed images were created by the technologist.  Radiation optimization: All CT scans at this facility use  at least one of these dose optimization techniques:  automated exposure control; mA and/or kV adjustment per  patient size (includes targeted exams where dose is matched  to clinical indication); or iterative reconstruction.  Contrast material: OMNI350; Contrast volume: 100 ml;  Contrast route: INTRAVENOUS (IV);     COMPARISON:  No relevant prior studies available.    FINDINGS:  Pulmonary arteries: Left lower lobe pulmonary emboli  present. Right upper lobe segmental pulmonary emboli.  Segmental pulmonary emboli in the right lower lobe.  Aorta: Unremarkable. No aortic aneurysm. No aortic  dissection.    Lungs: Bilateral lower lobe atelectasis. Mild airspace  disease and minimal consolidation right lung base.  Pleural spaces: Small right pleural effusion.  Heart: Unremarkable. No cardiomegaly. No pericardial  effusion.  Heart RV/LV ratio: RV/LV ratio 0.7.  Lymph nodes: Bilateral axillary calcified lymph nodes.  Right calcified axillary lymph node measures 22 mm.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Lymph node calcification, Pleural effusion, Pulmonary embolism, Scan with contrast abnormal
Clinical narrative: Patient presented with chest pain and was ruled out for COVID. had CT  chest: IMPRESSION:  1. Bilateral pulmonary emboli.  2. Normal heart ratio.  3. Bilateral lower lobe atelectasis and possible developing  pulmonary infarcts.  4. Bilateral calcified axillary lymph nodes.    PROCEDURE INFORMATION:  Exam: CTA Chest With Contrast  Exam date and time: 1/27/2022 3:06 PM  Age: 39 years old     TECHNIQUE:  Imaging protocol: Computed tomographic angiography of the  chest with contrast.  3D rendering (Not supervised by radiologist): MIP and/or 3D  reconstructed images were created by the technologist.  Radiation optimization: All CT scans at this facility use  at least one of these dose optimization techniques:  automated exposure control; mA and/or kV adjustment per  patient size (includes targeted exams where dose is matched  to clinical indication); or iterative reconstruction.  Contrast material: OMNI350; Contrast volume: 100 ml;  Contrast route: INTRAVENOUS (IV);     COMPARISON:  No relevant prior studies available.    FINDINGS:  Pulmonary arteries: Left lower lobe pulmonary emboli  present. Right upper lobe segmental pulmonary emboli.  Segmental pulmonary emboli in the right lower lobe.  Aorta: Unremarkable. No aortic aneurysm. No aortic  dissection.    Lungs: Bilateral lower lobe atelectasis. Mild airspace  disease and minimal consolidation right lung base.  Pleural spaces: Small right pleural effusion.  Heart: Unremarkable. No cardiomegaly. No pericardial  effusion.  Heart RV/LV ratio: RV/LV ratio 0.7.  Lymph nodes: Bilateral axillary calcified lymph nodes.  Right calcified axillary lymph node measures 22 mm.
Age: 13.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Patient has received ped dose by mistake, he is 13 yro
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Blood test normal, Cardiac function test normal, Chest pain, Chills
Clinical narrative: temperature dropped to 95.5 at 7:28pm pm teeth chattering chest pain abdominal pain. went into emergency room .  gotten extremely cold. body temp went back to 96 within 23min.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling cold, X-ray normal
Clinical narrative: temperature dropped to 95.5 at 7:28pm pm teeth chattering chest pain abdominal pain. went into emergency room .  gotten extremely cold. body temp went back to 96 within 23min.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, COVID-19 pneumonia, Computerised tomogram thorax abnormal, Cough
Clinical narrative: admission for acute hypoxic respiratory failure secondary to COVID-19 pneumonia.  Patient notes that her symptoms started approximately on 11/21, and she has had worsening shortness of breath and cough since that time.  She tested positive for COVID-19 on 11/23.  She notes that she has had 2 COVID-19 vaccinations, both Moderna.  She notes that she has been repeatedly tested for COVID-19 for work, and has been negative up until the positive test on the 23rd.  Other than shortness of breath and cough, the patient endorses nausea, diarrhea.  She has no other complaints at this time.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Dyspnoea, Lung opacity, Nausea, SARS-CoV-2 test positive
Clinical narrative: admission for acute hypoxic respiratory failure secondary to COVID-19 pneumonia.  Patient notes that her symptoms started approximately on 11/21, and she has had worsening shortness of breath and cough since that time.  She tested positive for COVID-19 on 11/23.  She notes that she has had 2 COVID-19 vaccinations, both Moderna.  She notes that she has been repeatedly tested for COVID-19 for work, and has been negative up until the positive test on the 23rd.  Other than shortness of breath and cough, the patient endorses nausea, diarrhea.  She has no other complaints at this time.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Muscle twitching
Clinical narrative: Began to notice sporadic twitching/muscle spasm events, almost exclusively in the inner thigh area of both legs several weeks after receiving the second dose of the Pfizer/BioNTech Covid vaccine. This was the first time I remember experiencing these sensations. Since they aren't debilitating, I haven't sought medical consult/diagnosis/testing of any sort. I noticed it most pronounced during October/November/December 2021, when I was in a higher altitude (4000 - 5000 feet) area, which I'm not sure if there is any correlation to or not.
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Acute kidney injury, Acute respiratory failure, Azotaemia, Blood albumin decreased, Blood chloride decreased
Clinical narrative: presented to the emergency department complaints of shortness of breath.  Patient reports that she was her usual state of health until approximately 1 week ago when she started noticing increased shortness of breath.  Patient reports that ever since then, her symptoms have continued to worsen.  Patient has had multiple episodes of fevers and chills.  Reports that she has had loose stools as well.  Her appetite has been very poor and her oral intake has been minimal over the past 2-3 days.  Patient reports that typically, she is able to get around and do her day-to-day activities however, has been unable to even go to the bathroom and back without significant shortness of breath.  Was found to have acute hypoxem respiratory failure, secondary to sepsis in the setting of COVID-19 pneumonia.  Chest x-ray negative for any acute findings. Lab work consistent with leukocytosis 12.3, lactic acidosis 6.4, erythrocytosis 18.6, hypochloremia 97, hyperglycemia 117, uremia 47, acute renal failure, and hypoalbuminemia 3.4.  Initial troponin 49 and BNP 6200.  EKG independently reviewed and negative for any acute ST elevations or depressions.  T-wave inversions noted in V6.  Patient hospitalized for COVID-19 treatment.  Discharged 1/27/2022.    Pfizer 9/15/21 & 10/16/21
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood glucose normal, Blood lactic acid, Blood urea increased, Brain natriuretic peptide increased, COVID-19
Clinical narrative: presented to the emergency department complaints of shortness of breath.  Patient reports that she was her usual state of health until approximately 1 week ago when she started noticing increased shortness of breath.  Patient reports that ever since then, her symptoms have continued to worsen.  Patient has had multiple episodes of fevers and chills.  Reports that she has had loose stools as well.  Her appetite has been very poor and her oral intake has been minimal over the past 2-3 days.  Patient reports that typically, she is able to get around and do her day-to-day activities however, has been unable to even go to the bathroom and back without significant shortness of breath.  Was found to have acute hypoxem respiratory failure, secondary to sepsis in the setting of COVID-19 pneumonia.  Chest x-ray negative for any acute findings. Lab work consistent with leukocytosis 12.3, lactic acidosis 6.4, erythrocytosis 18.6, hypochloremia 97, hyperglycemia 117, uremia 47, acute renal failure, and hypoalbuminemia 3.4.  Initial troponin 49 and BNP 6200.  EKG independently reviewed and negative for any acute ST elevations or depressions.  T-wave inversions noted in V6.  Patient hospitalized for COVID-19 treatment.  Discharged 1/27/2022.    Pfizer 9/15/21 & 10/16/21
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19 pneumonia, Chest X-ray normal, Chills, Decreased appetite, Diarrhoea
Clinical narrative: presented to the emergency department complaints of shortness of breath.  Patient reports that she was her usual state of health until approximately 1 week ago when she started noticing increased shortness of breath.  Patient reports that ever since then, her symptoms have continued to worsen.  Patient has had multiple episodes of fevers and chills.  Reports that she has had loose stools as well.  Her appetite has been very poor and her oral intake has been minimal over the past 2-3 days.  Patient reports that typically, she is able to get around and do her day-to-day activities however, has been unable to even go to the bathroom and back without significant shortness of breath.  Was found to have acute hypoxem respiratory failure, secondary to sepsis in the setting of COVID-19 pneumonia.  Chest x-ray negative for any acute findings. Lab work consistent with leukocytosis 12.3, lactic acidosis 6.4, erythrocytosis 18.6, hypochloremia 97, hyperglycemia 117, uremia 47, acute renal failure, and hypoalbuminemia 3.4.  Initial troponin 49 and BNP 6200.  EKG independently reviewed and negative for any acute ST elevations or depressions.  T-wave inversions noted in V6.  Patient hospitalized for COVID-19 treatment.  Discharged 1/27/2022.    Pfizer 9/15/21 & 10/16/21
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Dyspnoea exertional, Electrocardiogram ST segment normal, Electrocardiogram T wave inversion, Hyperglycaemia
Clinical narrative: presented to the emergency department complaints of shortness of breath.  Patient reports that she was her usual state of health until approximately 1 week ago when she started noticing increased shortness of breath.  Patient reports that ever since then, her symptoms have continued to worsen.  Patient has had multiple episodes of fevers and chills.  Reports that she has had loose stools as well.  Her appetite has been very poor and her oral intake has been minimal over the past 2-3 days.  Patient reports that typically, she is able to get around and do her day-to-day activities however, has been unable to even go to the bathroom and back without significant shortness of breath.  Was found to have acute hypoxem respiratory failure, secondary to sepsis in the setting of COVID-19 pneumonia.  Chest x-ray negative for any acute findings. Lab work consistent with leukocytosis 12.3, lactic acidosis 6.4, erythrocytosis 18.6, hypochloremia 97, hyperglycemia 117, uremia 47, acute renal failure, and hypoalbuminemia 3.4.  Initial troponin 49 and BNP 6200.  EKG independently reviewed and negative for any acute ST elevations or depressions.  T-wave inversions noted in V6.  Patient hospitalized for COVID-19 treatment.  Discharged 1/27/2022.    Pfizer 9/15/21 & 10/16/21
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoalbuminaemia, Hypochloraemia, Hypophagia, Lactic acidosis, Leukocytosis
Clinical narrative: presented to the emergency department complaints of shortness of breath.  Patient reports that she was her usual state of health until approximately 1 week ago when she started noticing increased shortness of breath.  Patient reports that ever since then, her symptoms have continued to worsen.  Patient has had multiple episodes of fevers and chills.  Reports that she has had loose stools as well.  Her appetite has been very poor and her oral intake has been minimal over the past 2-3 days.  Patient reports that typically, she is able to get around and do her day-to-day activities however, has been unable to even go to the bathroom and back without significant shortness of breath.  Was found to have acute hypoxem respiratory failure, secondary to sepsis in the setting of COVID-19 pneumonia.  Chest x-ray negative for any acute findings. Lab work consistent with leukocytosis 12.3, lactic acidosis 6.4, erythrocytosis 18.6, hypochloremia 97, hyperglycemia 117, uremia 47, acute renal failure, and hypoalbuminemia 3.4.  Initial troponin 49 and BNP 6200.  EKG independently reviewed and negative for any acute ST elevations or depressions.  T-wave inversions noted in V6.  Patient hospitalized for COVID-19 treatment.  Discharged 1/27/2022.    Pfizer 9/15/21 & 10/16/21
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Polycythaemia, Pyrexia, Red blood cell sedimentation rate normal, SARS-CoV-2 test positive, Sepsis
Clinical narrative: presented to the emergency department complaints of shortness of breath.  Patient reports that she was her usual state of health until approximately 1 week ago when she started noticing increased shortness of breath.  Patient reports that ever since then, her symptoms have continued to worsen.  Patient has had multiple episodes of fevers and chills.  Reports that she has had loose stools as well.  Her appetite has been very poor and her oral intake has been minimal over the past 2-3 days.  Patient reports that typically, she is able to get around and do her day-to-day activities however, has been unable to even go to the bathroom and back without significant shortness of breath.  Was found to have acute hypoxem respiratory failure, secondary to sepsis in the setting of COVID-19 pneumonia.  Chest x-ray negative for any acute findings. Lab work consistent with leukocytosis 12.3, lactic acidosis 6.4, erythrocytosis 18.6, hypochloremia 97, hyperglycemia 117, uremia 47, acute renal failure, and hypoalbuminemia 3.4.  Initial troponin 49 and BNP 6200.  EKG independently reviewed and negative for any acute ST elevations or depressions.  T-wave inversions noted in V6.  Patient hospitalized for COVID-19 treatment.  Discharged 1/27/2022.    Pfizer 9/15/21 & 10/16/21